Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TADALAFIL USP (NON-STERILE DRUG SUBSTANCE), with a corresponding US DMF Number 25694.
Remarkably, this DMF maintains an Active status since its submission on January 18, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 31, 2013, and payment made on September 18, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II